Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03831516 · ClinicalTrials.gov registry record
Non-Invasive 3D Mapping for Identifying Origin and Preferential Propagation of Ventricular Arrhythmias
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 30
- Enrollment target
NCT03831516 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 30 participants.
The verdict
NCT03831516 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study will measure the diagnostic sensitivity and specificity of the Medtronic CardioInsight wearable 252 electrode vest in predicting the chamber of origin of premature ventricular complexes (PVCs) and compare its diagnostic accuracy with the standard 12- lead ECG.
Interventions
- DIAGNOSTIC_TEST Non Invasive Electroanatomical Mapping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-01-04 |
| Est. Completion | 2022-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03831516
The ClinicalTrials.gov registry entry for NCT03831516 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non Invasive Electroanatomical Mapping is the first listed.
NCT03831516 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03831516 about?
NCT03831516 is a clinical study titled "Non-Invasive 3D Mapping for Identifying Origin and Preferential Propagation of Ventricular Arrhythmias". This study will measure the diagnostic sensitivity and specificity of the Medtronic CardioInsight wearable 252 electrode vest in predicting the chamber of origin of premature ventricular complexes (PVCs) and compare its diagnostic accuracy with the standard 12- lead ECG.
What is the current status of trial NCT03831516?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2019-01-04. Estimated completion is 2022-03-01.
What interventions are being tested in trial NCT03831516?
The interventions under investigation include: Non Invasive Electroanatomical Mapping (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03831516?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.